12:46 PM
 | 
Jun 26, 2018
 |  BC Extra  |  Financial News

Precision BioSciences raises $110M in series B

Genome editing company Precision BioSciences Inc. (Durham, N.C.) raised $110 million in an oversubscribed series B round led by new investor ArrowMark Partners.

Other new Investors included Franklin Templeton, Cowen Healthcare Investments, Brace Pharma Capital, Pontifax AgTech, OCV Partners, Adage Capital Management, Cormorant...

Read the full 192 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >